NCT02798731 Physiologic Assessment of Microvascular Function in Heart Transplant Patients
| NCT ID | NCT02798731 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Samsung Medical Center |
| Condition | Cardiac Allograft Vasculopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2016-05 |
| Primary Completion | 2030-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2016-05 with a primary completion date of 2030-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to evaluate the impact of early microvascular disease assessed by coronary physiologic indices such as fractional flow reserve (FFR), coronary flow reserve (CFR), index of microvascular resistance (IMR) on future occurrence of cardiac allograft vasculopathy (CAV) in heart transplant recipients.
Eligibility Criteria
Inclusion Criteria: * Subject over age of 18 * Patients received heart transplant Exclusion Criteria: * Patients with cardiogenic shock * Patients with unstable vital sign that precludes coronary angiography * Patients with major bleeding in last 3 months * Patients with active bleeding * Patients with coagulopathy * Patients with severe valvular heart disease * Patients who refused to provide informed consent
Contact & Investigator
Joo Myung Lee, MD, MPH
PRINCIPAL INVESTIGATOR
Samsung Medical Center
Frequently Asked Questions
Who can join the NCT02798731 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Cardiac Allograft Vasculopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02798731 currently recruiting?
Yes, NCT02798731 is actively recruiting participants. Contact the research team at drone80@hanmail.net for enrollment information.
Where is the NCT02798731 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT02798731 clinical trial?
NCT02798731 is sponsored by Samsung Medical Center. The principal investigator is Joo Myung Lee, MD, MPH at Samsung Medical Center. The trial plans to enroll 200 participants.